Cervical cancer is the second most commonly diagnosed cancer and the third leading cause of cancer death among females in less developed countries. The most significant cause of cervical cancer is persistent papillomavirus infection. For many years, the papanicolaou (Pap) test has been the standard method for cervical cancer screening, reducing the incidence by 60%-90% and the death rate by 90%.Primary prevention of cervical cancer is now possible via immunisation with highly efficacious HPV vaccines secondary prevention has gained impetus with the advent of sensitive HPV DNA testing to improve traditional Pap cytology screening programmes.
Impact Factor
2022: 6.012
This work is licensed under a